Showing results (241-250 of 246) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 246 results.
Oncotarget|April 14, 2017
Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology "UniCAR"Anja Feldmann, Claudia Arndt, Ralf Bergmann, et al.
Oncoimmunology|October 25, 2019
A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCARClaudia Arndt, Anja Feldmann, Stefanie Koristka, et al.
Endocrine-Related Cancer|October 28, 2020
HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomasNicole Bechmann, Mats Leif Moskopp, Martin Ullrich, et al.
The Journal of Pathology|May 29, 2020
Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomasPaal W Wallace, Catleen Conrad, Sascha Brückmann, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2023
Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic ResponsesAlessa Fischer, Simon Kloos, Umberto Maccio, et al.
Endocrine-Related Cancer|March 24, 2022
Personalized drug testing in human pheochromocytoma/paraganglioma primary culturesKatharina Wang, Ina Schütze, Sebastian Gulde, et al.
Pageof 25